Search type: go_term
Results for query: regulation of gene expression
| Gene Symbol | Gene Name | Links to Senescence |
|---|---|---|
| ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
U: 1
D: 1
|
| ACACB | acetyl-Coenzyme A carboxylase beta |
U: 3
D: 4
|
| ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
U: 3
|
| ACTA1 | actin alpha 1, skeletal muscle |
U: 3
|
| ACTA2 | actin alpha 2, smooth muscle |
U: 5
D: 4
|
| ACTB | actin beta |
U: 2
D: 2
|
| ACTC1 | actin alpha cardiac muscle 1 |
U: 4
D: 1
|
| ACTG2 | actin gamma 2, smooth muscle |
U: 1
D: 1
|
| ADAM19 | a disintegrin and metallopeptidase domain 19 (meltrin beta) |
U: 2
|
| ADM2 | adrenomedullin 2 |
U: 4
D: 1
|
| ADNP | activity-dependent neuroprotective protein |
D: 1
|
| ADTRP | androgen dependent TFPI regulating protein |
U: 3
D: 1
|
| AEBP2 | AE binding protein 2 |
U: 1
|
| AFDN | afadin, adherens junction formation factor |
D: 1
|
| AFF1 | AF4/FMR2 family, member 1 |
U: 2
D: 1
|
| AFF3 | AF4/FMR2 family, member 3 |
U: 2
D: 1
|
| AFF4 | AF4/FMR2 family, member 4 |
U: 2
|
| AGO1 | argonaute RISC catalytic subunit 1 |
D: 1
|
| AGO2 | argonaute RISC catalytic subunit 2 |
U: 1
D: 3
|
| AGO3 | argonaute RISC catalytic subunit 3 |
U: 1
|
| AGO4 | argonaute RISC component 4 |
D: 1
|
| AGR2 | anterior gradient 2 |
D: 2
|
| AHR | aryl-hydrocarbon receptor |
U: 3
D: 2
|
| AKT1 | thymoma viral proto-oncogene 1 |
U: 21
D: 24
|
| ALDH1A2 | aldehyde dehydrogenase family 1, subfamily A2 |
D: 2
|
| ALOX12 | arachidonate 12-lipoxygenase |
U: 1
|
| ALPK2 | alpha-kinase 2 |
U: 1
D: 1
|
| AMH | anti-Mullerian hormone |
D: 2
|
| ANAPC2 | anaphase promoting complex subunit 2 |
U: 2
|
| ANGPT1 | angiopoietin 1 |
U: 3
D: 3
|
| ANK2 | ankyrin 2, brain |
U: 2
D: 2
|
| ANK3 | ankyrin 3, epithelial |
U: 1
D: 1
|
| APBA1 | amyloid beta (A4) precursor protein binding, family A, member 1 |
U: 2
|
| APBA2 | amyloid beta (A4) precursor protein-binding, family A, member 2 |
U: 1
D: 1
|
| APBA3 | amyloid beta (A4) precursor protein-binding, family A, member 3 |
U: 2
|
| APLN | apelin |
U: 1
D: 3
|
| APOB | apolipoprotein B |
D: 1
|
| APOE | apolipoprotein E |
U: 4
D: 2
|
| APP | amyloid beta (A4) precursor protein |
U: 6
D: 2
|
| AR | androgen receptor |
U: 1
D: 1
|
| ARID4A | AT rich interactive domain 4A (RBP1-like) |
D: 1
|
| ARNTL | aryl hydrocarbon receptor nuclear translocator-like |
U: 2
D: 1
|
| ARRB2 | arrestin, beta 2 |
D: 1
|
| ARX | aristaless related homeobox |
D: 1
|
| ASCL1 | achaete-scute family bHLH transcription factor 1 |
D: 1
|
| ATF2 | activating transcription factor 2 |
D: 1
|
| ATF4 | activating transcription factor 4 |
U: 2
D: 1
|
| ATG14 | autophagy related 14 |
U: 1
|
| ATM | ataxia telangiectasia mutated |
U: 28
D: 1
|
| ATOH8 | atonal bHLH transcription factor 8 |
D: 4
|
| ATP13A2 | ATPase type 13A2 |
U: 3
D: 2
|
| ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 |
U: 4
|
| ATP6V1B1 | ATPase, H+ transporting, lysosomal V1 subunit B1 |
U: 1
|
| ATP7A | ATPase, Cu++ transporting, alpha polypeptide |
U: 2
|
| ATXN7L3B | ataxin 7-like 3B |
U: 1
|
| AURKA | aurora kinase A |
D: 18
|
| ADIPOR2 | adiponectin receptor 2 |
D: 2
|
| AGER | advanced glycosylation end product-specific receptor |
U: 2
D: 1
|
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
U: 4
D: 1
|
| AHI1 | Abelson helper integration site 1 |
U: 1
D: 1
|
| AKIRIN2 | akirin 2 |
D: 1
|
| AKT2 | thymoma viral proto-oncogene 2 |
U: 1
D: 1
|
| ALKBH1 | alkB homolog 1, histone H2A dioxygenase |
D: 2
|
| ATF3 | activating transcription factor 3 |
U: 3
D: 2
|
| ATF5 | activating transcription factor 5 |
U: 3
|
| AXIN1 | axin 1 |
U: 1
D: 1
|
| BAK1 | BCL2-antagonist/killer 1 |
U: 4
D: 1
|
| BAZ1B | bromodomain adjacent to zinc finger domain 1B |
D: 1
|
| BCL11A | B cell CLL/lymphoma 11A (zinc finger protein) |
U: 1
|
| BCL2 | B cell leukemia/lymphoma 2 |
U: 11
D: 5
|
| BHLHE40 | basic helix-loop-helix family, member e40 |
U: 8
D: 2
|
| BHLHE41 | basic helix-loop-helix family, member e41 |
U: 3
|
| BMI1 | BMI1 proto-oncogene, polycomb ring finger |
U: 4
D: 28
|
| BMP2 | bone morphogenetic protein 2 |
U: 6
D: 1
|
| BMP4 | bone morphogenetic protein 4 |
U: 5
D: 1
|
| BMP6 | bone morphogenetic protein 6 |
U: 2
D: 1
|
| BMP7 | bone morphogenetic protein 7 |
U: 5
D: 3
|
| BRAF | Braf transforming gene |
U: 24
D: 4
|
| BRCA1 | breast cancer 1, early onset |
U: 2
D: 10
|
| BRIP1 | BRCA1 interacting protein C-terminal helicase 1 |
D: 2
|
| BCL11B | B cell leukemia/lymphoma 11B |
U: 1
|
| BMP10 | bone morphogenetic protein 10 |
U: 1
|
| C1QTNF1 | C1q and tumor necrosis factor related protein 1 |
U: 1
|
| C9ORF116 | chromosome 9 open reading frame 116 |
U: 2
|
| CALCOCO1 | calcium binding and coiled coil domain 1 |
U: 2
|
| CALR | calreticulin |
D: 3
|
| CAMK2N1 | calcium/calmodulin-dependent protein kinase II inhibitor 1 |
U: 2
D: 1
|
| CASR | calcium-sensing receptor |
D: 1
|
| CAV1 | caveolin 1, caveolae protein |
U: 15
D: 7
|
| CAVIN3 | caveolae associated 3 |
D: 2
|
| CAVIN4 | caveolae associated 4 |
U: 1
|
| CCDC3 | coiled-coil domain containing 3 |
U: 1
|
| CCL3 | C-C motif chemokine ligand 3 |
U: 11
D: 1
|
| CCN2 | cellular communication network factor 2 |
U: 2
D: 3
|
| CCN3 | cellular communication network factor 3 |
U: 1
|
| CCNB1 | cyclin B1 |
D: 13
|
| CCR1 | chemokine (C-C motif) receptor 1 |
U: 2
D: 1
|
| CD28 | CD28 antigen |
U: 1
D: 2
|
| CD34 | CD34 antigen |
U: 2
D: 3
|
| CD36 | CD36 molecule |
U: 4
D: 2
|
| CD46 | CD46 antigen, complement regulatory protein |
U: 1
D: 2
|
| CD74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
D: 4
|
| CDC37 | cell division cycle 37 |
U: 2
|
| CDH1 | cadherin 1 |
U: 2
|
| CDH3 | cadherin 3 |
U: 1
|
| CDH5 | cadherin 5 |
U: 1
D: 3
|
| CDK1 | cyclin-dependent kinase 1 |
U: 1
D: 11
|
| CDK11A | cyclin dependent kinase 11A |
U: 1
|
| CDK2 | cyclin-dependent kinase 2 |
U: 2
D: 14
|
| CDK4 | cyclin-dependent kinase 4 |
U: 1
D: 17
|
| CDK6 | cyclin-dependent kinase 6 |
U: 1
D: 9
|
| CDKN1A | cyclin-dependent kinase inhibitor 1A (P21) |
U: 209
D: 24
|
| CDKN2B-AS1 | CDKN2B antisense RNA 1 |
U: 2
D: 1
|
| CIART | circadian associated repressor of transcription | |
| CILP | cartilage intermediate layer protein, nucleotide pyrophosphohydrolase |
U: 2
D: 2
|
| CITED1 | Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
D: 1
|
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
U: 1
D: 3
|
| CLDN5 | claudin 5 |
U: 1
D: 2
|
| CLU | clusterin |
U: 3
D: 5
|
| CNPY2 | canopy FGF signaling regulator 2 |
D: 1
|
| CNTN1 | contactin 1 |
U: 1
D: 1
|
| COL2A1 | collagen, type II, alpha 1 |
U: 2
D: 3
|
| CPNE1 | copine I |
U: 1
|
| CREB3L1 | cAMP responsive element binding protein 3-like 1 |
U: 2
|
| CREBZF | CREB/ATF bZIP transcription factor |
U: 1
D: 1
|
| CRH | corticotropin releasing hormone |
D: 1
|
| CRIP1 | cysteine-rich protein 1 (intestinal) |
D: 1
|
| CRKL | v-crk avian sarcoma virus CT10 oncogene homolog-like |
U: 1
D: 1
|
| CRP | C-reactive protein, pentraxin-related |
U: 1
|
| CRY1 | cryptochrome 1 (photolyase-like) |
D: 1
|
| CRY2 | cryptochrome 2 (photolyase-like) |
U: 1
|
| CSF1 | colony stimulating factor 1 (macrophage) |
U: 5
|
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) |
U: 11
D: 2
|
| CSNK1D | casein kinase 1, delta |
U: 1
|
| CSNK1E | casein kinase 1, epsilon |
U: 1
|
| CTCF | CCCTC-binding factor |
D: 2
|
| CTCFL | CCCTC-binding factor (zinc finger protein)-like |
D: 1
|
| CTSH | cathepsin H |
U: 3
|
| CYP26B1 | cytochrome P450, family 26, subfamily b, polypeptide 1 |
U: 3
D: 1
|
| CCL2 | chemokine (C-C motif) ligand 2 |
U: 39
D: 6
|
| CCL5 | chemokine (C-C motif) ligand 5 |
U: 13
D: 1
|
| CD40LG | CD40 ligand |
U: 1
|
| CD44 | CD44 antigen |
U: 6
D: 2
|
| CDKN2A | cyclin dependent kinase inhibitor 2A |
U: 238
D: 5
|
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha |
U: 4
D: 1
|
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta |
U: 9
D: 1
|
| CHD8 | chromodomain helicase DNA binding protein 8 |
U: 1
|
| CHEK1 | checkpoint kinase 1 |
U: 3
D: 9
|
| CKAP5 | cytoskeleton associated protein 5 |
D: 2
|
| CLN3 | ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
U: 1
|
| CNN2 | calponin 2 |
U: 2
D: 1
|
| COMP | cartilage oligomeric matrix protein |
U: 2
D: 3
|
| CREB1 | cAMP responsive element binding protein 1 |
D: 2
|
| CREB3L2 | cAMP responsive element binding protein 3-like 2 |
U: 1
D: 1
|
| CREBBP | CREB binding protein |
U: 1
D: 2
|
| CREM | cAMP responsive element modulator |
U: 2
D: 2
|
| CRNDE | colorectal neoplasia differentially expressed (non-protein coding) |
D: 1
|
| CRYAB | crystallin, alpha B |
U: 5
D: 1
|
| CTNNB1 | catenin (cadherin associated protein), beta 1 |
U: 7
D: 2
|
| DDRGK1 | DDRGK domain containing 1 |
U: 3
|
| DDX21 | DExD-box helicase 21 |
D: 3
|
| DDX58 | DEAD/H box helicase 58 |
U: 2
D: 1
|
| DEK | DEK proto-oncogene |
D: 3
|
| DGKQ | diacylglycerol kinase, theta |
U: 2
|
| DICER1 | dicer 1, ribonuclease type III |
D: 6
|
| DIP2A | disco interacting protein 2 homolog A |
U: 1
|
| DIRAS3 | DIRAS family GTPase 3 |
D: 1
|
| DKK1 | dickkopf WNT signaling pathway inhibitor 1 |
U: 7
D: 2
|
| DLL4 | delta like canonical Notch ligand 4 |
U: 1
D: 2
|
| DNM1L | dynamin 1-like |
U: 1
D: 6
|
| DNMT1 | DNA methyltransferase (cytosine-5) 1 |
U: 2
D: 7
|
| DNMT3A | DNA methyltransferase 3A |
D: 3
|
| DNMT3B | DNA methyltransferase 3B |
D: 4
|
| DRD1 | dopamine receptor D1 |
D: 2
|
| DRD2 | dopamine receptor D2 |
U: 1
|
| DROSHA | drosha, ribonuclease type III |
D: 1
|
| DTNBP1 | dystrobrevin binding protein 1 |
D: 2
|
| DYSF | dysferlin |
U: 3
D: 2
|
| DLK1 | delta like non-canonical Notch ligand 1 |
U: 1
D: 1
|
| DLL1 | delta like canonical Notch ligand 1 |
U: 1
D: 2
|
| DLX5 | distal-less homeobox 5 |
U: 2
D: 1
|
| DMD | dystrophin, muscular dystrophy |
U: 2
D: 2
|
| E2F1 | E2F transcription factor 1 |
U: 6
D: 13
|
| EED | embryonic ectoderm development |
D: 1
|
| EGF | epidermal growth factor |
U: 4
D: 5
|
| EGR1 | early growth response 1 |
U: 4
D: 5
|
| EIF2AK3 | eukaryotic translation initiation factor 2 alpha kinase 3 |
U: 2
D: 1
|
| EMILIN1 | elastin microfibril interfacer 1 |
U: 1
D: 4
|
| ENG | endoglin |
U: 4
D: 5
|
| EP300 | E1A binding protein p300 |
U: 3
D: 6
|
| EPB41L4B | erythrocyte membrane protein band 4.1 like 4b |
U: 1
|
| EPB41L5 | erythrocyte membrane protein band 4.1 like 5 |
U: 2
|
| EPC1 | enhancer of polycomb homolog 1 |
D: 2
|
| EPCAM | epithelial cell adhesion molecule |
D: 2
|
| EPHB2 | Eph receptor B2 |
U: 2
D: 3
|
| ERBB3 | erb-b2 receptor tyrosine kinase 3 |
U: 1
D: 1
|
| ERP29 | endoplasmic reticulum protein 29 |
D: 1
|
| ESR1 | estrogen receptor 1 (alpha) |
U: 2
D: 4
|
| ETS1 | E26 avian leukemia oncogene 1, 5' domain |
U: 2
D: 2
|
| EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit |
U: 1
D: 26
|
| EZR | ezrin |
U: 1
D: 1
|
| EDN1 | endothelin 1 |
U: 5
D: 1
|
| EIF2AK4 | eukaryotic translation initiation factor 2 alpha kinase 4 |
U: 1
|
| EIF4A3 | eukaryotic translation initiation factor 4A3 |
D: 1
|
| EMX2 | empty spiracles homeobox 2 |
D: 1
|
| EN1 | engrailed 1 |
U: 2
|
| EOMES | eomesodermin |
U: 2
D: 2
|
| EPM2A | epilepsy, progressive myoclonic epilepsy, type 2 gene alpha |
U: 1
|
| ERBB2 | erb-b2 receptor tyrosine kinase 2 |
U: 9
|
| ETV4 | ets variant 4 |
D: 3
|
| F2 | coagulation factor II |
U: 2
|
| F3 | coagulation factor III, tissue factor |
U: 2
D: 2
|
| FAM98A | family with sequence similarity 98, member A |
U: 3
D: 1
|
| FAM98B | family with sequence similarity 98, member B |
D: 1
|
| FBXO4 | F-box protein 4 |
U: 1
D: 1
|
| FBXW7 | F-box and WD-40 domain protein 7 |
U: 1
D: 1
|
| FERMT1 | fermitin family member 1 |
U: 1
|
| FEZF2 | FEZ family zinc finger 2 |
D: 1
|
| FGF2 | fibroblast growth factor 2 |
U: 14
D: 6
|
| FGF5 | fibroblast growth factor 5 |
U: 2
D: 1
|
| FGFR4 | fibroblast growth factor receptor 4 |
D: 3
|
| FLCN | folliculin |
U: 1
|
| FLOT2 | flotillin 2 |
D: 1
|
| FN1 | fibronectin 1 |
U: 9
D: 5
|
| FOXD1 | forkhead box D1 |
U: 1
D: 2
|
| FOXP1 | forkhead box P1 |
U: 2
D: 3
|
| FTX | Ftx transcript, Xist regulator (non-protein coding) |
U: 1
|
| FUBP1 | far upstream element (FUSE) binding protein 1 |
U: 2
D: 2
|
| FUBP3 | far upstream element (FUSE) binding protein 3 |
U: 1
|
| FUT8 | fucosyltransferase 8 |
U: 1
|
| FYN | Fyn proto-oncogene |
D: 2
|
| FAS | Fas (TNF receptor superfamily member 6) |
U: 4
D: 1
|
| FBLN1 | fibulin 1 |
U: 2
D: 2
|
| FGF10 | fibroblast growth factor 10 |
D: 1
|
| FGF4 | fibroblast growth factor 4 | |
| FGFR1 | fibroblast growth factor receptor 1 |
U: 2
|
| FGFR2 | fibroblast growth factor receptor 2 |
U: 3
D: 1
|
| FGFR3 | fibroblast growth factor receptor 3 |
U: 3
D: 1
|
| FMR1 | FMRP translational regulator 1 |
D: 1
|
| FOS | FBJ osteosarcoma oncogene |
U: 3
D: 8
|
| FOXA1 | forkhead box A1 |
U: 3
|
| FOXA2 | forkhead box A2 |
D: 1
|
| FOXC1 | forkhead box C1 |
U: 2
D: 1
|
| FOXG1 | forkhead box G1 |
U: 1
D: 1
|
| FOXN1 | forkhead box N1 |
U: 1
D: 2
|
| FOXP3 | forkhead box P3 |
U: 1
|
| GABPA | GA repeat binding protein, alpha |
D: 4
|
| GAS6 | growth arrest specific 6 |
U: 3
D: 4
|
| GCNT2 | glucosaminyl (N-acetyl) transferase 2, I-branching enzyme |
U: 1
|
| GDNF | glial cell line derived neurotrophic factor |
U: 5
|
| GFPT1 | glutamine fructose-6-phosphate transaminase 1 |
U: 2
D: 1
|
| GJA1 | gap junction protein, alpha 1 |
U: 2
D: 2
|
| GLMN | glomulin, FKBP associated protein |
D: 1
|
| GNRH1 | gonadotropin releasing hormone 1 |
D: 1
|
| GPER1 | G protein-coupled estrogen receptor 1 |
U: 1
D: 1
|
| GPX1 | glutathione peroxidase 1 |
U: 4
D: 7
|
| GSK3B | glycogen synthase kinase 3 beta |
U: 1
D: 6
|
| GSN | gelsolin |
U: 6
D: 1
|
| GATA3 | GATA binding protein 3 |
U: 1
|
| GATA4 | GATA binding protein 4 |
U: 5
|
| GATA6 | GATA binding protein 6 |
U: 4
D: 1
|
| GLI3 | GLI-Kruppel family member GLI3 |
D: 2
|
| GRHL3 | grainyhead like transcription factor 3 |
U: 1
D: 2
|
| H19 | H19, imprinted maternally expressed transcript |
U: 2
D: 5
|
| H3C1 | H3 clustered histone 1 |
D: 1
|
| H3C10 | H3 clustered histone 10 | |
| H3C4 | H3 clustered histone 4 | |
| H3C8 | H3 clustered histone 8 | |
| H4C8 | H4 clustered histone 8 | |
| HAVCR2 | hepatitis A virus cellular receptor 2 |
U: 3
|
| HCFC1 | host cell factor C1 |
D: 1
|
| HDAC1 | histone deacetylase 1 |
U: 3
D: 7
|
| HDAC2 | histone deacetylase 2 |
U: 1
D: 4
|
| HDAC3 | histone deacetylase 3 |
D: 2
|
| HDAC4 | histone deacetylase 4 |
U: 1
D: 6
|
| HDAC5 | histone deacetylase 5 |
U: 2
D: 1
|
| HDAC6 | histone deacetylase 6 |
D: 3
|
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 |
U: 1
D: 4
|
| HEY2 | hairy/enhancer-of-split related with YRPW motif 2 |
D: 2
|
| HFE | homeostatic iron regulator |
D: 1
|
| HGS | HGF-regulated tyrosine kinase substrate |
U: 1
|
| HIF1A | hypoxia inducible factor 1, alpha subunit |
U: 4
D: 8
|
| HINFP | histone H4 transcription factor |
U: 1
|
| HMG20A | high mobility group 20A |
D: 1
|
| HMGA2 | high mobility group AT-hook 2 |
U: 3
D: 2
|
| HMGN5 | high mobility group nucleosome binding domain 5 |
D: 1
|
| HNF4A | hepatic nuclear factor 4, alpha |
U: 2
|
| HNRNPK | heterogeneous nuclear ribonucleoprotein K |
D: 1
|
| HNRNPU | heterogeneous nuclear ribonucleoprotein U |
U: 1
D: 2
|
| HRAS | Harvey rat sarcoma virus oncogene |
U: 32
|
| HSPA1A | heat shock protein family A (Hsp70) member 1A |
U: 4
D: 7
|
| HSPA1B | heat shock protein family A (Hsp70) member 1B |
U: 3
D: 3
|
| HUWE1 | HECT, UBA and WWE domain containing 1 |
U: 1
|
| HES1 | hes family bHLH transcription factor 1 |
U: 2
D: 4
|
| HMGB2 | high mobility group box 2 |
U: 1
D: 9
|
| HNRNPD | heterogeneous nuclear ribonucleoprotein D |
D: 4
|
| HNRNPDL | heterogeneous nuclear ribonucleoprotein D-like |
D: 2
|
| HOXA11 | homeobox A11 |
U: 1
|
| HOXA9 | homeobox A9 |
D: 2
|
| HOXD10 | homeobox D10 |
D: 1
|
| HOXD11 | homeobox D11 |
D: 1
|
| HOXD9 | homeobox D9 |
U: 1
|
| HSF1 | heat shock factor 1 |
U: 1
D: 3
|
| HSPA4 | heat shock protein 4 |
U: 1
D: 1
|
| HSPA8 | heat shock protein 8 |
U: 2
D: 1
|
| ID1 | inhibitor of DNA binding 1, HLH protein |
U: 1
D: 20
|
| ID2 | inhibitor of DNA binding 2 |
D: 3
|
| ID3 | inhibitor of DNA binding 3 |
U: 2
D: 7
|
| ID4 | inhibitor of DNA binding 4 |
U: 2
D: 3
|
| IFI16 | interferon gamma inducible protein 16 |
U: 4
D: 2
|
| IFNG | interferon gamma |
U: 13
|
| IFNGR1 | interferon gamma receptor 1 |
U: 3
D: 2
|
| IGF1 | insulin-like growth factor 1 |
U: 12
D: 7
|
| IGF2 | insulin like growth factor 2 |
U: 3
D: 2
|
| IGF2BP2 | insulin-like growth factor 2 mRNA binding protein 2 |
U: 5
D: 1
|
| IGF2BP3 | insulin-like growth factor 2 mRNA binding protein 3 |
D: 1
|
| IHH | Indian hedgehog |
U: 1
|
| IL10 | interleukin 10 |
U: 4
D: 3
|
| IL13 | interleukin 13 |
U: 3
|
| IL1A | interleukin 1 alpha |
U: 31
D: 6
|
| IL1B | interleukin 1 beta |
U: 48
D: 9
|
| IL33 | interleukin 33 |
U: 1
D: 2
|
| IL34 | interleukin 34 |
U: 2
D: 1
|
| IL36B | interleukin 36 beta |
U: 1
|
| IL4 | interleukin 4 |
U: 4
|
| IL6 | interleukin 6 |
U: 97
D: 20
|
| IL7R | interleukin 7 receptor |
U: 1
D: 1
|
| INHBA | inhibin beta-A |
U: 4
D: 1
|
| INPPL1 | inositol polyphosphate phosphatase-like 1 |
U: 3
|
| INSM1 | insulinoma-associated 1 |
D: 1
|
| IQGAP3 | IQ motif containing GTPase activating protein 3 |
D: 5
|
| ITGA3 | integrin alpha 3 |
U: 4
D: 1
|
| ITGAX | integrin alpha X |
U: 2
|
| ITGB8 | integrin beta 8 |
U: 3
D: 2
|
| IKBKG | inhibitor of kappaB kinase gamma |
D: 1
|
| IKZF1 | IKAROS family zinc finger 1 |
U: 1
|
| IL16 | interleukin 16 |
U: 1
D: 3
|
| IL18 | interleukin 18 |
U: 8
D: 1
|
| IL3 | interleukin 3 |
U: 1
|
| IL7 | interleukin 7 |
U: 5
|
| INS1 | insulin I |
D: 1
|
| INSR | insulin receptor |
U: 2
D: 2
|
| IREB2 | iron responsive element binding protein 2 |
U: 1
D: 1
|
| IRF1 | interferon regulatory factor 1 |
U: 5
D: 1
|
| IRF3 | interferon regulatory factor 3 |
U: 3
|
| IRF7 | interferon regulatory factor 7 |
U: 5
D: 1
|
| IRS1 | insulin receptor substrate 1 |
U: 2
D: 3
|
| ITGB3 | integrin beta 3 |
U: 5
D: 2
|
| JARID2 | jumonji and AT-rich interaction domain containing 2 |
U: 1
D: 1
|
| JAG1 | jagged 1 |
U: 3
D: 6
|
| KAT2A | lysine acetyltransferase 2A |
U: 1
|
| KAT2B | lysine acetyltransferase 2B |
U: 4
D: 1
|
| KDM1B | lysine (K)-specific demethylase 1B |
D: 1
|
| KDM4A | lysine (K)-specific demethylase 4A |
D: 3
|
| KDM4C | lysine (K)-specific demethylase 4C |
U: 1
D: 2
|
| KDM5A | lysine (K)-specific demethylase 5A |
U: 1
D: 2
|
| KDM5B | lysine (K)-specific demethylase 5B |
U: 3
D: 2
|
| KDM8 | lysine (K)-specific demethylase 8 |
D: 1
|
| KDR | kinase insert domain protein receptor |
U: 2
D: 5
|
| KHSRP | KH-type splicing regulatory protein |
U: 1
D: 1
|
| KIF1B | kinesin family member 1B |
U: 1
D: 1
|
| KIT | KIT proto-oncogene receptor tyrosine kinase |
U: 1
D: 2
|
| KLF2 | Kruppel-like factor 2 (lung) |
U: 2
D: 5
|
| KLF4 | Kruppel-like factor 4 (gut) |
U: 3
D: 7
|
| KMT2A | lysine (K)-specific methyltransferase 2A |
U: 1
D: 1
|
| KRAS | Kirsten rat sarcoma viral oncogene homolog |
U: 18
D: 3
|
| KAT6A | K(lysine) acetyltransferase 6A |
D: 6
|
| KCNQ1OT1 | KCNQ1 overlapping transcript 1 |
U: 2
|
| KDM3A | lysine (K)-specific demethylase 3A |
D: 1
|
| KDM6B | KDM1 lysine (K)-specific demethylase 6B |
U: 10
D: 1
|
| KEAP1 | kelch-like ECH-associated protein 1 |
U: 3
D: 1
|
| KLF15 | Kruppel-like factor 15 |
U: 1
D: 3
|
| KLF5 | Kruppel-like factor 5 |
D: 1
|
| KMT2C | lysine (K)-specific methyltransferase 2C |
U: 2
D: 2
|
| KMT2D | lysine (K)-specific methyltransferase 2D |
D: 1
|
| L3MBTL1 | L3MBTL1 histone methyl-lysine binding protein |
U: 1
|
| LAMP3 | lysosomal-associated membrane protein 3 |
D: 1
|
| LAMTOR5 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 5 |
U: 1
|
| LCN2 | lipocalin 2 |
U: 2
D: 1
|
| LDLR | low density lipoprotein receptor |
U: 3
D: 2
|
| LEF1 | lymphoid enhancer binding factor 1 |
U: 1
|
| LGALS9 | lectin, galactose binding, soluble 9 |
U: 3
D: 2
|
| LGMN | legumain |
U: 2
D: 1
|
| LGR4 | leucine-rich repeat-containing G protein-coupled receptor 4 |
U: 1
D: 1
|
| LHX2 | LIM homeobox protein 2 |
U: 2
D: 1
|
| LIMS1 | LIM and senescent cell antigen-like domains 1 |
U: 2
D: 1
|
| LMNA | lamin A |
U: 17
D: 12
|
| LOX | lysyl oxidase |
U: 2
D: 4
|
| LRRC32 | leucine rich repeat containing 32 |
U: 3
|
| LBH | limb-bud and heart |
U: 2
|
| LCK | lymphocyte protein tyrosine kinase |
U: 1
|
| LIF | leukemia inhibitory factor |
U: 6
D: 3
|
| LRRK2 | leucine-rich repeat kinase 2 |
U: 1
|
| MACROH2A1 | macroH2A.1 histone | |
| MACROH2A2 | macroH2A.2 histone | |
| MAGED1 | melanoma antigen, family D, 1 |
U: 1
D: 1
|
| MAP2K1 | mitogen-activated protein kinase kinase 1 |
U: 3
|
| MAP2K2 | mitogen-activated protein kinase kinase 2 |
U: 5
D: 1
|
| MAPK1 | mitogen-activated protein kinase 1 |
U: 17
D: 6
|
| MAPK10 | mitogen-activated protein kinase 10 |
U: 1
D: 2
|
| MAPK11 | mitogen-activated protein kinase 11 |
U: 4
|
| MAPK12 | mitogen-activated protein kinase 12 |
U: 2
D: 1
|
| MAPK13 | mitogen-activated protein kinase 13 |
U: 2
D: 2
|
| MAPK14 | mitogen-activated protein kinase 14 |
U: 44
D: 6
|
| MAPK15 | mitogen-activated protein kinase 15 |
D: 1
|
| MAPK3 | mitogen-activated protein kinase 3 |
U: 10
D: 4
|
| MAPK4 | mitogen-activated protein kinase 4 |
U: 1
D: 1
|
| MAPK6 | mitogen-activated protein kinase 6 |
U: 1
|
| MAPK7 | mitogen-activated protein kinase 7 |
D: 1
|
| MAPK8 | mitogen-activated protein kinase 8 |
U: 5
D: 3
|
| MAPK9 | mitogen-activated protein kinase 9 |
U: 1
D: 3
|
| MAPT | microtubule-associated protein tau |
U: 1
D: 1
|
| MATR3 | matrin 3 |
U: 1
|
| MAZ | MYC-associated zinc finger protein (purine-binding transcription factor) |
U: 1
D: 1
|
| MDM2 | transformed mouse 3T3 cell double minute 2 |
U: 6
D: 18
|
| MECOM | MDS1 and EVI1 complex locus |
U: 2
D: 4
|
| MECP2 | methyl CpG binding protein 2 |
U: 2
D: 3
|
| MED23 | mediator complex subunit 23 |
U: 2
|
| MED26 | mediator complex subunit 26 |
U: 2
|
| MEF2C | myocyte enhancer factor 2C |
D: 2
|
| MESP1 | mesoderm posterior 1 |
U: 2
D: 1
|
| MEX3D | mex-3 RNA binding family member D |
D: 1
|
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
U: 3
D: 5
|
| MIR106B | microRNA 106b |
U: 2
D: 1
|
| MIR125A | microRNA 125a |
U: 1
|
| MIR138-1 | microRNA 138-1 |
U: 1
|
| MIR140 | microRNA 140 |
U: 1
|
| MIR146A | microRNA 146a |
U: 2
D: 5
|
| MIR155 | microRNA 155 |
U: 1
|
| MIR17 | microRNA 17 |
D: 1
|
| MIR181A1 | microRNA 181a-1 |
U: 2
|
| MIR181A2 | microRNA 181a-2 |
U: 1
|
| MIR182 | microRNA 182 |
D: 1
|
| MIR19B1 | microRNA 19b-1 |
U: 1
|
| MIR20A | microRNA 20a | |
| MIR21 | microRNA 21 |
U: 2
D: 1
|
| MIR214 | microRNA 214 |
D: 1
|
| MIR27B | microRNA 27b |
U: 4
|
| MIR29A | microRNA 29a |
U: 3
|
| MIR29B1 | microRNA 29b-1 |
U: 2
|
| MIR29C | microRNA 29c |
U: 2
D: 1
|
| MIR34A | microRNA 34a |
U: 7
D: 2
|
| MIR449A | microRNA 449a |
U: 1
|
| MIR492 | microRNA 492 |
U: 1
|
| MIR98 | microRNA 98 |
D: 1
|
| MITF | melanogenesis associated transcription factor |
U: 3
D: 4
|
| MKKS | McKusick-Kaufman syndrome |
D: 1
|
| MMP8 | matrix metallopeptidase 8 |
U: 3
|
| MOK | MOK protein kinase |
D: 1
|
| MORC2 | MORC family CW-type zinc finger 2 |
U: 1
|
| MOV10 | Mov10 RISC complex RNA helicase |
U: 1
D: 1
|
| MPHOSPH8 | M-phase phosphoprotein 8 |
U: 1
|
| MSN | moesin |
U: 1
D: 2
|
| MSX1 | msh homeobox 1 |
D: 1
|
| MSX2 | msh homeobox 2 |
U: 1
D: 3
|
| MT3 | metallothionein 3 |
U: 2
D: 1
|
| MTF2 | metal response element binding transcription factor 2 |
D: 1
|
| MTOR | mechanistic target of rapamycin kinase |
U: 36
D: 10
|
| MUSK | muscle, skeletal, receptor tyrosine kinase |
D: 1
|
| MYADM | myeloid-associated differentiation marker |
U: 1
D: 1
|
| MYBBP1A | MYB binding protein (P160) 1a |
U: 1
D: 2
|
| MYC | myelocytomatosis oncogene |
U: 7
D: 24
|
| MYCBP2 | MYC binding protein 2, E3 ubiquitin protein ligase |
D: 1
|
| MYCN | v-myc avian myelocytomatosis viral related oncogene, neuroblastoma derived |
D: 3
|
| MYD88 | myeloid differentiation primary response gene 88 |
U: 1
|
| MYLK2 | myosin, light polypeptide kinase 2, skeletal muscle |
D: 2
|
| MYO1C | myosin IC |
U: 1
D: 2
|
| MAEL | maelstrom spermatogenic transposon silencer |
D: 1
|
| MAF | avian musculoaponeurotic fibrosarcoma oncogene homolog |
U: 2
D: 2
|
| MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
U: 1
D: 1
|
| MAPK8IP3 | mitogen-activated protein kinase 8 interacting protein 3 |
U: 1
|
| MBD1 | methyl-CpG binding domain protein 1 |
U: 1
D: 1
|
| MEF2A | myocyte enhancer factor 2A |
U: 2
D: 1
|
| MEN1 | multiple endocrine neoplasia 1 |
U: 1
D: 1
|
| MET | met proto-oncogene |
U: 1
D: 1
|
| MIR136 | microRNA 136 |
U: 1
|
| MIR137 | microRNA 137 |
U: 1
|
| MIR146 | microRNA 146 |
U: 1
|
| MIR184 | microRNA 184 |
U: 1
|
| MIR186 | microRNA 186 |
U: 2
|
| MIR188 | microRNA 188 |
U: 1
|
| MIR205 | microRNA 205 |
U: 2
D: 1
|
| MIR208A | microRNA 208a |
U: 1
|
| MIR217 | microRNA 217 |
U: 2
|
| MIR21A | microRNA 21a |
U: 1
|
| MIR23A | microRNA 23a |
U: 4
|
| MIR23B | microRNA 23b |
U: 1
|
| MIR24-1 | microRNA 24-1 |
U: 1
|
| MIR24-2 | microRNA 24-2 | |
| MIR34B | microRNA 34b |
U: 1
|
| MIR34C | microRNA 34c |
U: 2
|
| MIR449B | microRNA 449b |
D: 1
|
| MIR543 | microRNA 543 |
D: 1
|
| MIR675 | microRNA 675 |
D: 1
|
| MIR744 | microRNA 744 |
D: 1
|
| MMP12 | matrix metallopeptidase 12 |
U: 9
D: 1
|
| MRTFB | myocardin related transcription factor B | |
| MST1 | macrophage stimulating 1 (hepatocyte growth factor-like) |
U: 1
D: 1
|
| MYB | myeloblastosis oncogene |
U: 1
D: 1
|
| MYOCD | myocardin |
U: 1
D: 1
|
| MYOD1 | myogenic differentiation 1 |
U: 1
|
| MYT1 | myelin transcription factor 1 |
U: 2
D: 1
|
| NAMPT | nicotinamide phosphoribosyltransferase |
U: 5
D: 5
|
| NANOG | Nanog homeobox |
U: 1
D: 6
|
| NANOS1 | nanos C2HC-type zinc finger 1 |
U: 2
|
| NCOA2 | nuclear receptor coactivator 2 |
D: 3
|
| NCOA3 | nuclear receptor coactivator 3 |
U: 1
D: 2
|
| NDFIP2 | Nedd4 family interacting protein 2 |
U: 1
|
| NELL1 | NEL-like 1 |
U: 1
D: 2
|
| NEUROD1 | neurogenic differentiation 1 |
D: 1
|
| NF1 | neurofibromin 1 |
U: 2
D: 2
|
| NFE2L2 | nuclear factor, erythroid derived 2, like 2 |
U: 4
D: 16
|
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
U: 19
D: 7
|
| NGF | nerve growth factor |
U: 3
|
| NGFR | nerve growth factor receptor (TNFR superfamily, member 16) |
U: 2
|
| NHLRC1 | NHL repeat containing 1 |
U: 1
|
| NKX3-1 | NK3 homeobox 1 |
U: 2
|
| NLK | nemo like kinase |
U: 1
|
| NME1 | NME/NM23 nucleoside diphosphate kinase 1 |
U: 1
D: 1
|
| NOCT | nocturnin |
D: 1
|
| NOG | noggin |
U: 1
D: 1
|
| NOS1AP | nitric oxide synthase 1 adaptor protein |
U: 1
|
| NOS2 | nitric oxide synthase 2, inducible |
U: 7
D: 2
|
| NOS3 | nitric oxide synthase 3, endothelial cell |
U: 5
D: 13
|
| NOTCH1 | notch 1 |
U: 8
D: 5
|
| NOVA1 | NOVA alternative splicing regulator 1 |
D: 1
|
| NPAS2 | neuronal PAS domain protein 2 |
U: 2
|
| NPAT | nuclear protein in the AT region |
D: 1
|
| NR1D1 | nuclear receptor subfamily 1, group D, member 1 |
U: 2
D: 1
|
| NR5A1 | nuclear receptor subfamily 5, group A, member 1 |
D: 1
|
| NRG1 | neuregulin 1 |
U: 2
D: 3
|
| NRIP1 | nuclear receptor interacting protein 1 |
U: 2
|
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 |
U: 2
|
| NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 |
U: 2
|
| NUDT21 | nudix (nucleoside diphosphate linked moiety X)-type motif 21 |
D: 1
|
| NWD1 | NACHT and WD repeat domain containing 1 |
U: 1
|
| NFAT5 | nuclear factor of activated T cells 5 |
U: 4
D: 1
|
| NFATC1 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
D: 3
|
| NFATC2 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2 |
U: 1
D: 2
|
| NFE2 | nuclear factor, erythroid derived 2 |
U: 1
|
| NFE2L1 | nuclear factor, erythroid derived 2,-like 1 |
U: 1
|
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
U: 2
D: 6
|
| NIPBL | NIPBL cohesin loading factor |
D: 1
|
| NKX2-2 | NK2 homeobox 2 |
U: 1
D: 1
|
| NKX2-5 | NK2 homeobox 5 |
U: 1
D: 1
|
| NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) |
U: 3
|
| NPM1 | nucleophosmin 1 |
U: 3
D: 2
|
| NR1H2 | nuclear receptor subfamily 1, group H, member 2 |
U: 2
D: 2
|
| NR1I2 | nuclear receptor subfamily 1, group I, member 2 |
U: 1
|
| NR2F1 | nuclear receptor subfamily 2, group F, member 1 |
D: 1
|
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 |
D: 1
|
| NRAS | neuroblastoma ras oncogene |
U: 7
|
| NRXN1 | neurexin I |
U: 1
|
| OCLN | occludin |
U: 1
D: 1
|
| OGT | O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) |
U: 1
D: 2
|
| OLFM1 | olfactomedin 1 |
U: 2
D: 1
|
| OSR2 | odd-skipped related 2 |
U: 1
|
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
U: 3
|
| OPTN | optineurin |
U: 3
D: 1
|
| P2RX7 | purinergic receptor P2X, ligand-gated ion channel, 7 |
D: 1
|
| P2RY1 | purinergic receptor P2Y, G-protein coupled 1 |
U: 1
D: 1
|
| PARK7 | Parkinson disease (autosomal recessive, early onset) 7 |
U: 1
D: 2
|
| PARP1 | poly (ADP-ribose) polymerase family, member 1 |
U: 5
D: 8
|
| PARP10 | poly (ADP-ribose) polymerase family, member 10 |
U: 2
|
| PARP14 | poly (ADP-ribose) polymerase family, member 14 |
U: 4
D: 1
|
| PARP9 | poly (ADP-ribose) polymerase family, member 9 |
U: 4
|
| PAWR | PRKC, apoptosis, WT1, regulator |
U: 1
D: 2
|
| PAX6 | paired box 6 |
U: 1
D: 2
|
| PC | pyruvate carboxylase |
U: 1
|
| PCBP1 | poly(rC) binding protein 1 |
U: 1
|
| PCBP2 | poly(rC) binding protein 2 |
U: 1
D: 2
|
| PCBP3 | poly(rC) binding protein 3 |
U: 1
D: 1
|
| PCBP4 | poly(rC) binding protein 4 |
U: 1
D: 1
|
| PDCD10 | programmed cell death 10 |
U: 2
|
| PDCD5 | programmed cell death 5 |
U: 1
D: 1
|
| PDCL3 | phosducin-like 3 |
D: 1
|
| PDE2A | phosphodiesterase 2A, cGMP-stimulated |
U: 1
D: 3
|
| PDGFB | platelet derived growth factor, B polypeptide |
U: 4
D: 2
|
| PDGFRA | platelet derived growth factor receptor, alpha polypeptide |
U: 2
D: 2
|
| PER1 | period circadian clock 1 |
U: 1
D: 1
|
| PER2 | period circadian clock 2 |
U: 2
|
| PER3 | period circadian clock 3 |
U: 1
D: 1
|
| PF4 | platelet factor 4 |
U: 3
D: 1
|
| PGR | progesterone receptor |
U: 3
D: 2
|
| PHB | prohibitin |
U: 2
D: 2
|
| PHF19 | PHD finger protein 19 |
D: 3
|
| PHGDH | 3-phosphoglycerate dehydrogenase |
U: 1
D: 3
|
| PHLDA2 | pleckstrin homology like domain, family A, member 2 |
U: 2
D: 1
|
| PICALM | phosphatidylinositol binding clathrin assembly protein |
U: 1
|
| PID1 | phosphotyrosine interaction domain containing 1 |
U: 1
D: 1
|
| PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
U: 5
D: 5
|
| PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
U: 2
|
| PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
U: 2
D: 2
|
| PIK3R3 | phosphoinositide-3-kinase regulatory subunit 3 |
U: 2
|
| PIN1 | protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1 |
U: 1
D: 4
|
| PINK1 | PTEN induced putative kinase 1 |
U: 3
D: 6
|
| PKP1 | plakophilin 1 |
U: 2
|
| PKP3 | plakophilin 3 |
D: 1
|
| PLP1 | proteolipid protein (myelin) 1 |
D: 2
|
| PLSCR1 | phospholipid scramblase 1 |
U: 2
D: 1
|
| PML | promyelocytic leukemia |
U: 15
D: 2
|
| POFUT2 | protein O-fucosyltransferase 2 |
U: 4
|
| POGZ | pogo transposable element with ZNF domain |
D: 2
|
| POLR1A | RNA polymerase I subunit A |
D: 2
|
| POLR1B | RNA polymerase I subunit B |
D: 1
|
| POLR1C | RNA polymerase I and III subunit C |
U: 1
|
| POLR2H | RNA polymerase II, I and III subunit H |
U: 1
|
| POLR2K | RNA polymerase II, I and III subunit K |
D: 1
|
| POLR2L | RNA polymerase II, I and III subunit L |
D: 1
|
| POU3F1 | POU domain, class 3, transcription factor 1 |
U: 2
|
| POU3F2 | POU domain, class 3, transcription factor 2 |
D: 1
|
| POU3F3 | POU domain, class 3, transcription factor 3 |
D: 1
|
| POU4F1 | POU domain, class 4, transcription factor 1 |
D: 1
|
| POU5F1 | POU domain, class 5, transcription factor 1 |
U: 3
D: 7
|
| PPARA | peroxisome proliferator activated receptor alpha |
D: 8
|
| PPARGC1A | peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
U: 3
D: 13
|
| PPHLN1 | periphilin 1 |
D: 1
|
| PPM1D | protein phosphatase 1D magnesium-dependent, delta isoform |
U: 4
D: 5
|
| PPP1CA | protein phosphatase 1 catalytic subunit alpha |
U: 2
D: 1
|
| PPP1CB | protein phosphatase 1 catalytic subunit beta |
U: 1
D: 1
|
| PPP1CC | protein phosphatase 1 catalytic subunit gamma |
U: 1
D: 2
|
| PPP2CB | protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform |
U: 1
|
| PRDM1 | PR domain containing 1, with ZNF domain |
U: 1
D: 2
|
| PRDM10 | PR domain containing 10 |
U: 1
|
| PRDM11 | PR domain containing 11 |
U: 2
D: 1
|
| PRDM12 | PR domain containing 12 |
U: 1
|
| PRDM16 | PR domain containing 16 |
D: 2
|
| PRDM4 | PR domain containing 4 |
D: 1
|
| PRDM5 | PR/SET domain 5 |
D: 2
|
| PRDM6 | PR domain containing 6 |
U: 1
D: 2
|
| PRKAA1 | protein kinase, AMP-activated, alpha 1 catalytic subunit |
U: 9
D: 11
|
| PRKAA2 | protein kinase, AMP-activated, alpha 2 catalytic subunit |
U: 2
D: 4
|
| PRKAB1 | protein kinase, AMP-activated, beta 1 non-catalytic subunit |
D: 1
|
| PRKN | parkin RBR E3 ubiquitin protein ligase |
U: 5
D: 1
|
| PRMT5 | protein arginine N-methyltransferase 5 |
D: 3
|
| PRMT7 | protein arginine N-methyltransferase 7 |
D: 1
|
| PROX1 | prospero homeobox 1 |
U: 2
|
| PSEN1 | presenilin 1 |
U: 3
|
| PTEN | phosphatase and tensin homolog |
U: 6
D: 20
|
| PTGFR | prostaglandin F receptor |
D: 1
|
| PTHLH | parathyroid hormone-like peptide |
U: 1
D: 3
|
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
D: 2
|
| PTPRC | protein tyrosine phosphatase, receptor type, C |
U: 2
D: 2
|
| PTRH2 | peptidyl-tRNA hydrolase 2 |
U: 1
D: 1
|
| PUM2 | pumilio RNA-binding family member 2 |
U: 1
|
| PAK1 | p21 (RAC1) activated kinase 1 |
D: 1
|
| PANTR1 | POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 | |
| PATZ1 | POZ (BTB) and AT hook containing zinc finger 1 |
D: 3
|
| PDX1 | pancreatic and duodenal homeobox 1 |
D: 1
|
| PIK3R1 | phosphoinositide-3-kinase regulatory subunit 1 |
U: 1
|
| PITX3 | paired-like homeodomain transcription factor 3 |
D: 1
|
| PLAGL1 | pleiomorphic adenoma gene-like 1 |
U: 2
D: 2
|
| PMP22 | peripheral myelin protein 22 |
U: 2
D: 1
|
| POU2F1 | POU domain, class 2, transcription factor 1 |
U: 2
D: 1
|
| PPARD | peroxisome proliferator activator receptor delta |
U: 3
D: 4
|
| PPARG | peroxisome proliferator activated receptor gamma |
U: 7
D: 9
|
| PPP1R15A | protein phosphatase 1, regulatory subunit 15A |
U: 2
D: 4
|
| PPP3CA | protein phosphatase 3, catalytic subunit, alpha isoform |
U: 1
D: 1
|
| PPP3CB | protein phosphatase 3, catalytic subunit, beta isoform |
U: 1
D: 1
|
| PRKG2 | protein kinase, cGMP-dependent, type II |
D: 1
|
| PTGER4 | prostaglandin E receptor 4 (subtype EP4) |
U: 3
D: 2
|
| PTGES3 | prostaglandin E synthase 3 |
U: 1
D: 1
|
| QKI | QKI, KH domain containing RNA binding |
D: 1
|
| RAB27A | RAB27A, member RAS oncogene family |
U: 1
D: 2
|
| RAB3GAP1 | RAB3 GTPase activating protein subunit 1 |
U: 1
|
| RACK1 | receptor for activated C kinase 1 |
D: 1
|
| RAMP2 | receptor (calcitonin) activity modifying protein 2 |
D: 2
|
| RB1 | RB transcriptional corepressor 1 |
U: 37
D: 7
|
| RBBP4 | RB binding protein 4, chromatin remodeling factor |
U: 1
D: 2
|
| RBBP7 | RB binding protein 7, chromatin remodeling factor |
D: 1
|
| RBL1 | RB transcriptional corepressor like 1 |
U: 2
D: 3
|
| RBL2 | RB transcriptional corepressor like 2 |
U: 5
|
| RBMS3 | RNA binding motif, single stranded interacting protein |
U: 2
D: 1
|
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region |
D: 2
|
| RC3H1 | RING CCCH (C3H) domains 1 |
U: 1
|
| RC3H2 | ring finger and CCCH-type zinc finger domains 2 |
D: 2
|
| RDX | radixin |
U: 3
D: 1
|
| REL | reticuloendotheliosis oncogene |
U: 2
D: 1
|
| RELB | avian reticuloendotheliosis viral (v-rel) oncogene related B |
U: 2
D: 1
|
| REST | RE1-silencing transcription factor |
U: 2
|
| RGCC | regulator of cell cycle |
U: 1
D: 4
|
| RICTOR | RPTOR independent companion of MTOR, complex 2 |
U: 2
|
| RIMS1 | regulating synaptic membrane exocytosis 1 |
U: 2
|
| RIMS2 | regulating synaptic membrane exocytosis 2 |
U: 2
|
| RNASEH2B | ribonuclease H2, subunit B |
D: 3
|
| RNF187 | ring finger protein 187 |
U: 1
|
| RNF207 | ring finger protein 207 |
U: 1
|
| RNF39 | ring finger protein 39 |
U: 1
|
| RO60 | Ro60, Y RNA binding protein | |
| ROBO1 | roundabout guidance receptor 1 |
D: 2
|
| ROCK1 | Rho-associated coiled-coil containing protein kinase 1 |
D: 1
|
| ROCK2 | Rho-associated coiled-coil containing protein kinase 2 |
D: 2
|
| ROM1 | rod outer segment membrane protein 1 |
U: 1
D: 1
|
| RORA | RAR-related orphan receptor alpha |
U: 5
|
| ROS1 | Ros1 proto-oncogene |
U: 1
|
| RPL11 | ribosomal protein L11 |
U: 1
D: 1
|
| RPL23 | ribosomal protein L23 |
D: 1
|
| RPL5 | ribosomal protein L5 |
U: 2
|
| RPS3 | ribosomal protein S3 |
D: 1
|
| RPS7 | ribosomal protein S7 |
U: 1
D: 2
|
| RUNX1 | RUNX family transcription factor 1 |
U: 4
D: 1
|
| RCOR1 | REST corepressor 1 |
D: 1
|
| RELN | reelin |
D: 1
|
| RIPPLY1 | ripply transcriptional repressor 1 |
D: 1
|
| RNF41 | ring finger protein 41 |
U: 1
D: 1
|
| RPS6KA2 | ribosomal protein S6 kinase, polypeptide 2 |
U: 1
D: 2
|
| RUNX2 | runt related transcription factor 2 |
U: 4
D: 3
|
| RXRA | retinoid X receptor alpha |
U: 1
D: 3
|
| SART3 | squamous cell carcinoma antigen recognized by T cells 3 |
D: 1
|
| SERPINB9 | serine (or cysteine) peptidase inhibitor, clade B, member 9 |
D: 1
|
| SERPINF1 | serine (or cysteine) peptidase inhibitor, clade F, member 1 |
U: 5
D: 3
|
| SETDB1 | SET domain, bifurcated 1 |
D: 2
|
| SFMBT2 | Scm-like with four mbt domains 2 |
U: 1
D: 1
|
| SFRP1 | secreted frizzled-related protein 1 |
U: 2
D: 1
|
| SFRP2 | secreted frizzled-related protein 2 |
U: 2
D: 2
|
| SFRP4 | secreted frizzled-related protein 4 |
U: 2
D: 1
|
| SGMS1 | sphingomyelin synthase 1 |
U: 1
D: 1
|
| SHH | sonic hedgehog |
U: 2
D: 1
|
| SIRPA | signal-regulatory protein alpha |
U: 2
D: 1
|
| SIRT1 | sirtuin 1 |
U: 12
D: 110
|
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 |
U: 1
|
| SLC2A10 | solute carrier family 2 (facilitated glucose transporter), member 10 |
U: 4
|
| SLC38A2 | solute carrier family 38, member 2 |
D: 3
|
| SLC8A1 | solute carrier family 8 (sodium/calcium exchanger), member 1 |
U: 1
D: 2
|
| SLIT3 | slit guidance ligand 3 |
U: 2
D: 1
|
| SMAD1 | SMAD family member 1 |
U: 1
D: 1
|
| SMAD2 | SMAD family member 2 |
U: 2
D: 1
|
| SMAD3 | SMAD family member 3 |
U: 8
D: 2
|
| SMARCA5 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 |
D: 2
|
| SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 homolog (human) |
U: 1
|
| SMO | smoothened, frizzled class receptor |
U: 1
D: 3
|
| SNF8 | SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae) |
D: 1
|
| SORT1 | sortilin 1 |
U: 1
D: 1
|
| SOX11 | SRY (sex determining region Y)-box 11 |
D: 2
|
| SOX17 | SRY (sex determining region Y)-box 17 |
U: 2
D: 1
|
| SOX2 | SRY (sex determining region Y)-box 2 |
U: 3
D: 10
|
| SOX9 | SRY (sex determining region Y)-box 9 |
U: 2
D: 7
|
| SP1 | trans-acting transcription factor 1 |
U: 1
D: 2
|
| SPHK2 | sphingosine kinase 2 |
D: 1
|
| SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene |
U: 1
D: 1
|
| SPRY2 | sprouty RTK signaling antagonist 2 |
D: 4
|
| SRPK1 | serine/arginine-rich protein specific kinase 1 |
D: 1
|
| SRPK2 | serine/arginine-rich protein specific kinase 2 |
U: 1
|
| SRPK3 | serine/arginine-rich protein specific kinase 3 |
U: 1
|
| STAT3 | signal transducer and activator of transcription 3 |
U: 18
D: 6
|
| STC2 | stanniocalcin 2 |
U: 2
D: 1
|
| STK40 | serine/threonine kinase 40 |
U: 1
D: 1
|
| STOX1 | storkhead box 1 |
U: 1
D: 1
|
| STX1B | syntaxin 1B |
U: 1
|
| SUZ12 | SUZ12 polycomb repressive complex 2 subunit |
U: 1
D: 2
|
| SATB2 | special AT-rich sequence binding protein 2 |
D: 2
|
| SERPINE1 | serine (or cysteine) peptidase inhibitor, clade E, member 1 |
U: 38
D: 5
|
| SETD2 | SET domain containing 2 |
U: 1
D: 1
|
| SIX1 | sine oculis-related homeobox 1 |
D: 4
|
| SIX4 | sine oculis-related homeobox 4 |
D: 1
|
| SLIT2 | slit guidance ligand 2 |
U: 1
D: 1
|
| SOX6 | SRY (sex determining region Y)-box 6 |
U: 1
D: 1
|
| SOX8 | SRY (sex determining region Y)-box 8 |
U: 1
D: 1
|
| SRC | Rous sarcoma oncogene |
U: 2
D: 6
|
| SRSF6 | serine and arginine-rich splicing factor 6 |
D: 2
|
| STAT4 | signal transducer and activator of transcription 4 |
U: 1
|
| STING1 | stimulator of interferon response cGAMP interactor 1 |
U: 2
|
| TADA3 | transcriptional adaptor 3 |
U: 1
D: 3
|
| TAF10 | TATA-box binding protein associated factor 10 |
U: 1
|
| TAF1A | TATA-box binding protein associated factor, RNA polymerase I subunit A |
D: 1
|
| TAF1B | TATA-box binding protein associated factor, RNA polymerase I subunit B |
D: 1
|
| TAF1C | TATA-box binding protein associated factor, RNA polymerase I subunit C |
D: 2
|
| TAF1D | TATA-box binding protein associated factor, RNA polymerase I subunit D |
U: 1
|
| TAPBP | TAP binding protein |
U: 1
|
| TARDBP | TAR DNA binding protein |
D: 1
|
| TASOR | transcription activation suppressor | |
| TBP | TATA-box binding protein |
D: 1
|
| TBX6 | T-box 6 |
U: 1
D: 1
|
| TCF19 | transcription factor 19 |
U: 2
D: 3
|
| TCIRG1 | T cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 |
U: 1
D: 1
|
| TDG | thymine DNA glycosylase |
U: 2
D: 1
|
| TDRD7 | tudor domain containing 7 |
U: 1
|
| TERF2 | telomeric repeat binding factor 2 |
U: 2
D: 4
|
| TERT | telomerase reverse transcriptase |
U: 6
D: 60
|
| TESC | tescalcin |
D: 1
|
| TFAP2A | transcription factor AP-2, alpha |
U: 3
D: 1
|
| TFAP2C | transcription factor AP-2, gamma |
U: 2
D: 2
|
| TFEB | transcription factor EB |
D: 3
|
| TFRC | transferrin receptor |
U: 2
D: 1
|
| TGFB1 | transforming growth factor, beta 1 |
U: 49
D: 6
|
| TGFB2 | transforming growth factor, beta 2 |
U: 5
D: 1
|
| TGFBR1 | transforming growth factor, beta receptor I |
U: 5
|
| TGFBR2 | transforming growth factor, beta receptor II |
U: 4
D: 2
|
| TICAM1 | toll-like receptor adaptor molecule 1 |
U: 1
|
| TIPARP | TCDD-inducible poly(ADP-ribose) polymerase |
U: 2
D: 1
|
| TLE1 | transducin-like enhancer of split 1 |
D: 2
|
| TLR2 | toll-like receptor 2 |
U: 3
D: 1
|
| TLR3 | toll-like receptor 3 |
U: 4
D: 1
|
| TLR4 | toll-like receptor 4 |
U: 7
D: 2
|
| TLR6 | toll-like receptor 6 |
U: 1
D: 1
|
| TLR9 | toll-like receptor 9 |
U: 1
D: 1
|
| TMED2 | transmembrane p24 trafficking protein 2 |
U: 1
D: 3
|
| TMEM119 | transmembrane protein 119 |
U: 1
D: 2
|
| TMF1 | TATA element modulatory factor 1 |
D: 1
|
| TMPRSS4 | transmembrane protease, serine 4 |
U: 1
|
| TNC | tenascin C |
U: 1
D: 5
|
| TNF | tumor necrosis factor |
U: 48
D: 7
|
| TNRC6A | trinucleotide repeat containing adaptor 6A |
U: 1
D: 2
|
| TNRC6B | trinucleotide repeat containing adaptor 6B |
U: 1
|
| TNRC6C | trinucleotide repeat containing adaptor 6C |
D: 2
|
| TOB1 | transducer of ErbB-2.1 |
U: 2
|
| TOP1 | topoisomerase (DNA) I |
U: 2
D: 1
|
| TP53 | tumor protein p53 |
U: 243
D: 9
|
| TP53INP1 | tumor protein p53 inducible nuclear protein 1 |
U: 5
|
| TP73 | tumor protein p73 |
U: 4
D: 2
|
| TREM2 | triggering receptor expressed on myeloid cells 2 |
D: 1
|
| TRIM14 | tripartite motif-containing 14 |
U: 1
D: 1
|
| TRIM17 | tripartite motif-containing 17 |
U: 1
D: 2
|
| TRIM21 | tripartite motif-containing 21 |
U: 1
D: 2
|
| TRIM22 | tripartite motif containing 22 |
U: 3
D: 1
|
| TRIM26 | tripartite motif-containing 26 |
U: 1
|
| TRIM27 | tripartite motif-containing 27 |
D: 1
|
| TRIM38 | tripartite motif-containing 38 |
U: 1
|
| TRIM4 | tripartite motif containing 4 |
U: 1
|
| TRIM44 | tripartite motif-containing 44 |
D: 1
|
| TRIM58 | tripartite motif-containing 58 |
U: 1
|
| TRIM6 | tripartite motif-containing 6 |
D: 1
|
| TRIM68 | tripartite motif-containing 68 |
D: 1
|
| TSKU | tsukushi, small leucine rich proteoglycan |
D: 1
|
| TTBK1 | tau tubulin kinase 1 |
D: 1
|
| TTC21B | tetratricopeptide repeat domain 21B |
D: 1
|
| TTN | titin |
U: 2
D: 3
|
| TWIST1 | twist basic helix-loop-helix transcription factor 1 |
D: 14
|
| TBK1 | TANK-binding kinase 1 |
U: 2
|
| TBX21 | T-box 21 |
U: 3
|
| TCF12 | transcription factor 12 |
D: 3
|
| TCF3 | transcription factor 3 |
U: 1
D: 1
|
| TCF4 | transcription factor 4 |
U: 1
D: 4
|
| TEAD1 | TEA domain family member 1 |
U: 1
D: 1
|
| TFAP4 | transcription factor AP4 |
D: 3
|
| TGFB3 | transforming growth factor, beta 3 |
U: 1
D: 3
|
| TGFBR3 | transforming growth factor, beta receptor III |
U: 3
D: 2
|
| TGIF1 | TGFB-induced factor homeobox 1 |
U: 1
D: 4
|
| THOC2 | THO complex 2 |
U: 2
D: 1
|
| THOC5 | THO complex 5 |
U: 2
D: 2
|
| TMEM135 | transmembrane protein 135 |
U: 1
D: 1
|
| TMTC3 | transmembrane and tetratricopeptide repeat containing 3 |
U: 2
|
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1a |
U: 4
D: 2
|
| TNFSF11 | tumor necrosis factor (ligand) superfamily, member 11 |
U: 5
|
| TREX1 | three prime repair exonuclease 1 |
U: 1
D: 2
|
| TRIM24 | tripartite motif-containing 24 |
D: 2
|
| TRIM63 | tripartite motif-containing 63 |
U: 2
|
| TRP73 | transformation related protein 73 |
D: 3
|
| TRPV4 | transient receptor potential cation channel, subfamily V, member 4 |
U: 1
|
| TSHZ1 | teashirt zinc finger family member 1 |
D: 1
|
| TSHZ2 | teashirt zinc finger family member 2 |
U: 1
|
| TUG1 | taurine upregulated gene 1 |
U: 1
D: 1
|
| UBXN2A | UBX domain protein 2A |
D: 1
|
| UCA1 | urothelial cancer associated 1 |
U: 1
|
| UCN | urocortin |
U: 1
|
| UMODL1 | uromodulin-like 1 |
U: 1
|
| USP2 | ubiquitin specific peptidase 2 |
U: 1
D: 1
|
| UFL1 | UFM1 specific ligase 1 |
D: 1
|
| ULK1 | unc-51 like kinase 1 |
U: 2
|
| USP16 | ubiquitin specific peptidase 16 |
U: 1
D: 4
|
| VDR | vitamin D (1,25-dihydroxyvitamin D3) receptor |
U: 1
D: 2
|
| VEGFA | vascular endothelial growth factor A |
U: 10
D: 5
|
| VHL | von Hippel-Lindau tumor suppressor |
D: 2
|
| VPS35 | VPS35 retromer complex component |
U: 1
|
| VSIR | V-set immunoregulatory receptor |
U: 2
D: 1
|
| VASH1 | vasohibin 1 |
U: 3
D: 2
|
| VIM | vimentin |
U: 5
D: 2
|
| WBP2 | WW domain binding protein 2 |
U: 1
D: 1
|
| WDR35 | WD repeat domain 35 |
D: 2
|
| WHRN | whirlin |
U: 1
|
| WNT11 | wingless-type MMTV integration site family, member 11 |
U: 1
|
| WNT16 | wingless-type MMTV integration site family, member 16 |
U: 1
D: 1
|
| WNT3 | wingless-type MMTV integration site family, member 3 |
U: 3
D: 1
|
| WNT3A | wingless-type MMTV integration site family, member 3A |
U: 2
|
| WNT4 | wingless-type MMTV integration site family, member 4 |
U: 1
D: 3
|
| WNT5A | wingless-type MMTV integration site family, member 5A |
U: 4
|
| WNT6 | wingless-type MMTV integration site family, member 6 |
U: 1
|
| WT1 | Wilms tumor 1 homolog |
D: 2
|
| WARS | tryptophanyl-tRNA synthetase |
U: 3
D: 2
|
| WNT7A | wingless-type MMTV integration site family, member 7A |
U: 1
D: 1
|
| WNT7B | wingless-type MMTV integration site family, member 7B |
U: 3
D: 3
|
| XDH | xanthine dehydrogenase |
U: 2
D: 2
|
| YAP1 | yes-associated protein 1 |
U: 6
D: 13
|
| YBX1 | Y box protein 1 |
U: 1
D: 5
|
| YBX2 | Y box protein 2 |
U: 1
D: 1
|
| YBX3 | Y box protein 3 |
U: 1
|
| YY1 | YY1 transcription factor |
D: 1
|
| ZBTB16 | zinc finger and BTB domain containing 16 |
U: 1
D: 1
|
| ZBTB7B | zinc finger and BTB domain containing 7B |
U: 1
|
| ZC3H10 | zinc finger CCCH type containing 10 |
D: 1
|
| ZC3H12A | zinc finger CCCH type containing 12A |
U: 3
D: 1
|
| ZC3H7A | zinc finger CCCH type containing 7 A |
U: 1
|
| ZC3H7B | zinc finger CCCH type containing 7B |
U: 1
D: 1
|
| ZFHX3 | zinc finger homeobox 3 |
U: 1
|
| ZFP36L1 | zinc finger protein 36, C3H type-like 1 |
U: 2
D: 3
|
| ZFP64 | zinc finger protein 64 |
D: 1
|
| ZNF148 | zinc finger protein 148 |
D: 2
|
| ZNF345 | zinc finger protein 345 |
U: 1
D: 1
|
| ZNF385A | zinc finger protein 385A |
U: 1
|
| ZNF407 | zinc finger protein 407 |
D: 1
|
| ZNF438 | zinc finger protein 438 |
U: 1
D: 1
|
| ZNF462 | zinc finger protein 462 |
D: 1
|
| ZNF503 | zinc finger protein 503 |
U: 1
|
| ZNF507 | zinc finger protein 507 |
D: 2
|
| ZNF513 | zinc finger protein 513 |
D: 1
|
| ZNF597 | zinc finger protein 597 |
U: 1
|
| ZNF711 | zinc finger protein 711 |
D: 2
|
| ZPR1 | ZPR1 zinc finger |
D: 3
|
| ZBTB20 | zinc finger and BTB domain containing 20 |
D: 2
|
| ZFP91 | zinc finger protein 91 |
U: 1
|
| ZMPSTE24 | zinc metallopeptidase, STE24 |
D: 2
|
| ZSCAN2 | zinc finger and SCAN domain containing 2 |
D: 1
|